Sphingosylphosphorylcholine inhibits plasma cell differentiation and ameliorates experimental autoimmune encephalomyelitis

Sphingosylphosphorylcholine inhibits plasma cell differentiation and ameliorates experimental autoimmune encephalomyelitis

IntroductionMultiple sclerosis (MS) is a potentially disabling disease that damages the brain and spinal cord, inducing paralysis of the body. While MS has been known as a T-cell mediated disease, recent attention has been drawn to the involvement of B cells in its pathogenesis. Autoantibodies from...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Byunghyun Park, Yu Sun Jeong, Wonseok Hu, Mingyu Lee, Ji Cheol Kim, Geon Ho Bae, Yong-Soo Bae, Yoe-Sik Bae
Format:	Artikel
Sprache:	English
Veröffentlicht:	Frontiers Media S.A. 2023-06-01
Schriftenreihe:	Frontiers in Immunology
Schlagworte:	sphingosylphosphorylcholine plasma cells S1PR3 experimental autoimmune encephalomyelitis multiple sclerosis
Online Zugang:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1151511/full

Ähnliche Einträge

Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
von: Michael Basler, et al.
Veröffentlicht: (2014-01-01)

Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
von: Leonie Stolz, et al.
Veröffentlicht: (2017-07-01)

Immunomodulation Eliminates Inflammation in the Hippocampus in Experimental Autoimmune Encephalomyelitis, but Does Not Ameliorate Anxiety-Like Behavior
von: Pece Kocovski, et al.
Veröffentlicht: (2021-06-01)

ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis
von: Kaili Lu, et al.
Veröffentlicht: (2020-02-01)

Involvement of mTOR signaling in sphingosylphosphorylcholine-induced hypopigmentation effects
von: Jeong Hyo-Soon, et al.
Veröffentlicht: (2011-08-01)

Effect of Cordyceps sinensis on the Treatment of Experimental Autoimmune Encephalomyelitis: A Pilot Study on Mice Model
von: Shan-Shan Zhong, et al.
Veröffentlicht: (2017-01-01)

Immune Thymic Profile of the MOG-Induced Experimental Autoimmune Encephalomyelitis Mouse Model
von: Sofia P. das Neves, et al.
Veröffentlicht: (2018-10-01)

Silencing miR-150 Ameliorates Experimental Autoimmune Encephalomyelitis
von: Zhaolan Hu, et al.
Veröffentlicht: (2018-07-01)

Gliotoxin Aggravates Experimental Autoimmune Encephalomyelitis by Triggering Neuroinflammation
von: Thais Fernanda de Campos Fraga-Silva, et al.
Veröffentlicht: (2019-07-01)

Swimming Exercise Ameliorates Symptoms of MOG-Induced Experimental Autoimmune Encephalomyelitis by Inhibiting Inflammation and Demyelination in Rats
von: Ji-Youn Kim, et al.
Veröffentlicht: (2020-05-01)

Peptide immunotherapy in experimental autoimmune encephalomyelitis
von: Stephen M Anderton
Veröffentlicht: (2015-06-01)

From mishap to model: The origins and utility of experimental autoimmune encephalomyelitis
von: Emma L Walton
Veröffentlicht: (2015-06-01)

Oligodendrocyte-specific Argonaute profiling identifies microRNAs associated with experimental autoimmune encephalomyelitis
von: Qin Ma, et al.
Veröffentlicht: (2020-10-01)

Interferon-gamma ameliorates experimental autoimmune encephalomyelitis by inducing homeostatic adaptation of microglia
von: Juan E. Tichauer, et al.
Veröffentlicht: (2023-06-01)

Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
von: Dhaiban S, et al.
Veröffentlicht: (2020-09-01)

Phenethyl Ester of Gallic Acid Ameliorates Experimental Autoimmune Encephalomyelitis
von: Goran Stegnjaić, et al.
Veröffentlicht: (2022-12-01)

Hormones in experimental autoimmune encephalomyelitis (EAE) animal models
von: Ghareghani Majid, et al.
Veröffentlicht: (2021-05-01)

Effects of increased proliferation of human adipose tissue-derived mesenchymal stem cells by sphingosylphosphorylcholine on the survival of cryopreserved fat grafts
von: Bae Yong Chan, et al.
Veröffentlicht: (2018-01-01)

Oral Administration of Probiotic Enterococcus durans to Ameliorate Experimental Autoimmune Encephalomyelitis in Mice
von: Seyed Abdollah Samani, et al.
Veröffentlicht: (2022-01-01)

Senolytic treatment diminishes microglia and decreases severity of experimental autoimmune encephalomyelitis
von: Sienna S. Drake, et al.
Veröffentlicht: (2024-11-01)

Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms
von: M. Moransard, et al.
Veröffentlicht: (2017-10-01)

Modulation of Ryanodine Receptors Activity Alters the Course of Experimental Autoimmune Encephalomyelitis in Mice
von: Natalia C. Osipchuk, et al.
Veröffentlicht: (2021-12-01)

Effect of Voluntary Training after the Induction of Experimental Autoimmune Encephalomyelitis on Some Myelin-Producing Proteins in Female C57BL/6 Mice
von: Yasaman Honarmandnasab, et al.
Veröffentlicht: (2021-02-01)

Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis
von: Alba Sánchez-Fernández, et al.
Veröffentlicht: (2022-02-01)

Editorial: Pain in multiple sclerosis and experimental autoimmune encephalomyelitis
von: Amy Lovett-Racke, et al.
Veröffentlicht: (2022-11-01)

Therapeutic effect of nucleoside analogs on experimental autoimmune encephalomyelitis in dark agouti rats
von: Stojkov Danijela, et al.
Veröffentlicht: (2006-01-01)

IL-12p35 Inhibits Neuroinflammation and Ameliorates Autoimmune Encephalomyelitis
von: Jin Kyeong Choi, et al.
Veröffentlicht: (2017-10-01)

Amelioration of Experimental Autoimmune Encephalomyelitis in Alzheimer’s Disease Mouse Models: A Potential Role for Aβ
von: Changjie Shi, et al.
Veröffentlicht: (2022-03-01)

Treatment of Experimental Autoimmune Encephalomyelitis with an Inhibitor of Phosphodiesterase-8 (PDE8)
von: Chaitali P. Basole, et al.
Veröffentlicht: (2022-02-01)

Sex, aging and immunity in multiple sclerosis and experimental autoimmune encephalomyelitis: An intriguing interaction
von: Marina Boziki, et al.
Veröffentlicht: (2023-01-01)

Acute treatment with valproic acid and l-thyroxine ameliorates clinical signs of experimental autoimmune encephalomyelitis and prevents brain pathology in DA rats
von: Gonçalo Castelo-Branco, et al.
Veröffentlicht: (2014-11-01)

Clozapine Regulates Microglia and Is Effective in Chronic Experimental Autoimmune Encephalomyelitis
von: Ulaş Ceylan, et al.
Veröffentlicht: (2021-05-01)

Human microbiome-derived peptide affects the development of experimental autoimmune encephalomyelitis via molecular mimicryResearch in context
von: Xin Ma, et al.
Veröffentlicht: (2025-01-01)

Gestational Hypothyroxinemia Affects Its Offspring With a Reduced Suppressive Capacity Impairing the Outcome of the Experimental Autoimmune Encephalomyelitis
von: Henny Haensgen, et al.
Veröffentlicht: (2018-06-01)

Age related immune modulation of experimental autoimmune encephalomyelitis in PINK1 knockout mice
von: Davide Cossu, et al.
Veröffentlicht: (2022-11-01)

Interleukin-19 Abrogates Experimental Autoimmune Encephalomyelitis by Attenuating Antigen-Presenting Cell Activation
von: Hiroshi Horiuchi, et al.
Veröffentlicht: (2021-03-01)

Teriflunomide attenuates immunopathological changes in the Dark Agouti rat model of experimental autoimmune encephalomyelitis
von: Garth E. Ringheim, et al.
Veröffentlicht: (2013-10-01)

Eugenol ameliorates uveitis in mice with experimental autoimmune encephalomyelitis through the suppression of key inflammatory genes
von: Sungmoo Hong, et al.
Veröffentlicht: (2024-12-01)

In Vivo Induction of Regulatory T Cells Via CTLA‐4 Signaling Peptide to Control Autoimmune Encephalomyelitis and Prevent Disease Relapse
von: Gil‐Ran Kim, et al.
Veröffentlicht: (2021-07-01)

Oleanolic Acid Acetate Alleviates Symptoms of Experimental Autoimmune Encephalomyelitis in Mice by Regulating Toll-Like Receptor 2 Signaling
von: Minju Kim, et al.
Veröffentlicht: (2020-09-01)